Overview
Status
Active
Registry date
2009-08-31
Share capital
410,000.00 PLN
Registered address
76, 63-930 Grąbkowo, Poland
Financials
Revenue history
From the notes
| Current income tax (CIT due) | $0 |
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 87 days late).
- 202509/07/2026
- 202404/07/2025
- 202312/07/2024
- 202212/07/2023
- 202110/10/2022
- 202012/10/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Adam Karaś age 59 – President of the Management Board
Manner of representation
The persons authorised to make declarations of will on behalf of the company are: the President and the Vice-Presidents, each of them independently, or two members of the management board jointly, or a member of the management board jointly with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 410 | $110,750.95 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Genxone S.A. | $665,361.35 | genxone.eu | ||
| Bioscientia sp. z o.o. | $238,316.98 | bioscientia.pl | ||
| Cofactor sp. z o.o. | $136,474.66 | cofactor.pl | ||
| Microblic sp. z o.o. | $122,383.50 | microblic.pl | ||
| Future Designe sp. z o.o. | $97,145.59 | lumi-land.pl | ||
| Onconick sp. z o.o. | $39,587.95 | onconick.com | ||
| Data2biology sp. z o.o. | $28,567.58 | data2biology.com | ||
| Mamygeny sp. z o.o. | $8,232.62 | mamygeny.com | ||
| Innosil sp. z o.o. | $7,984.08 | innosil.pl | ||
| Fungotech sp. z o.o. | $187.68 | fungo.tech |
Change history
| Date | Event | |
|---|---|---|
| 2022-04-07 | PKD change (Removed: 34 codes) | |
| 2016-08-30 | Address change (73, 63-930, Grąbkowo → 76, 63-930, Grąbkowo) | |
| 2010-08-17 | Share capital increase (10,000.00 PLN → 410,000.00 PLN) | |
| 2009-08-31 | Entered in the register |
FAQ
The main business activity of BIO Omega focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on August 31, 2009.
The headquarters is located at: 76, 63-930 Grąbkowo.
The management board consists of: Adam Karaś (President of the Management Board).
The share capital of the company is PLN 410,000 (approx. $110,751).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
Last updated: 2026-11-16